[1
]Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA
[2
]Department of Medical Genetics, Box 134, Addenbrooke’s Hospital NHS Trust, Hills Road,
Cambridge CB2 0QQ
[3
]Molecular Oncology, Michael Smith Genome Sciences Centre, BC Cancer Agency, 675 West
10th Avenue, Vancouver V5Z 1L3, Canada
[4
]Centre for Translational and Applied Genomics, Michael Smith Genome Sciences Centre,
BC Cancer Agency, 675 West 10th Avenue, Vancouver V5Z 1L3, Canada
[5
]Department of Pathology, University of British Columbia, G227-2211 Wesbrook Mall,
British Columbia, Vancouver V6T 2B5, Canada
[6
]Department of Paediatrics, University of Cambridge, Hills Road, Cambridge, CB2 2XY
[7
]Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow,
Garscube Estate, Switchback Road, Bearsden, Glasgow, Scotland G61 1BD, United Kingdom.
[8
]West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, Scotland G4 0SF,
United Kingdom
[9
]The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst, and the Cancer Research
Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst,
Sydney, New South Wales 2010, Australia
[10
]Department of Surgery, Bankstown Hospital, Eldridge Road, Bankstown, Sydney, New South
Wales 2200, Australia
[11
]South Western Sydney Clinical School, Faculty of Medicine, University of New South
Wales, Liverpool, New South Wales 2170, Australia
[12
]Department of Haematology, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
[13
]Department of Haematology, University of Cambridge, Cambridge CB2 2XY, UK
[14
]Department of Oncology, Lund University, SE-221 85 Lund, Sweden
[15
]Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The
Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
[16
]The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine,
Faculty of Medicine, University of Oslo, Norway
[17
]Plateforme de Bioinformatique Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laennec,
69373 LYON CEDEX 08
[18
]NHL-BFM Study Center and Department of Pediatric Hematology and Oncology, University
Children’s Hospital, Münster, Germany
[19
]NHL-BFM Study Center and Department of Pediatric Hematology and Oncology, University
Children’s Hospital, Giessen, Germany
[20
]Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre,
Cambridge CB2 0RE
[21
]Breast Cancer Translational Res Lab - BCTL, Université Libre de Bruxelles - Institut
Jules Bordet, Boulevard de Waterloo, 125, B-1000 Brussels
[22
]Department of Theoretical Bioinformatics (B080), German Cancer Research Center (DKFZ),
Im Neuenheimer Feld 280, Heidelberg, Germany
[23
]Cancer Research Laboratory, Faculty of Medicine, Biomedical Centre, University of
Iceland, 101 Reykjavik, Iceland
[24
]Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
[25
]Department of Haemato-oncology, Institute of Cancer Research, London
[26
]Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Tokyo,
104-0045, Japan
[27
]Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg,
Germany
[28
]INSERM, UMR-674, Génomique Fonctionnelle des Tumeurs Solides, Institut Universitaire
d’Hematologie (IUH), Paris, France
[29
]Université Paris Descartes, Labex Immuno-oncology, Sorbonne Paris Cité, Faculté de
Médecine, Paris, France
[30
]The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
[31
]Section of Oncology, Department of Clinical Science, University of Bergen, 5020 Bergen,
Norway
[32
]Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway
[33
]The University of Queensland Centre for Clinical Research, School of Medicine and
Pathology Queensland, The Royal Brisbane & Women’s Hospital, Herston 4029,Brisbane,
QLD, Australia
[34
]Dpt. Bioquímica y Biología Molecular, IUOPA-Universidad de Oviedo, 33006 Oviedo, Spain
[35
]Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard
Medical School, Boston, MA, USA
[36
]Boston Veterans Administration Healthcare System, West Roxbury, MA
[37
]Clinical Experimental Oncology Laboratory, National Cancer Institute, Via Amendola,
209, 70126, Bari, Italy
[38
]Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, The University
of Queensland, St Lucia, Brisbane, Queensland 4072, Australia
[39
]Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA
[40
]Harvard Medical School, Boston, Massachusetts, USA
[41
]Department of Pathology, Brigham and Women’s Hospital 75 Francis St. Boston, MA 02115,
USA
[42
]Institute of Human Genetics, Christian-Albrechts-University, Kiel, Germany
[43
]Institute of Clinical Molecular Biology, Christian-Albrechts-University,Kiel, Germany
[44
]Division of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX,
Amsterdam, The Netherlands
[45
]Department of Radiation Oncology and department of Laboratory Medicine, Radboud University
Nijmegen Medical Centre, PO Box 9101, 6500HB Nijmegen,the Netherlands
[46
]Breakthrough Breast Cancer Research Unit, King’s College London School of Medicine,
London, UK
[47
]The Netherlands Cancer Institute, 121 Plesmanlaan, 1066 CX Amsterdam, The Netherlands
[48
]Institut Curie , Departement de Pathologie, INSERM U830, 26 rue d’Ulm 75248 PARIS
CEDEX 05, France
[49
]Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg,
Germany
[50
]Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Universitat
de Barcelona, IDIBAPS, 08036 Barcelona, Spain
[51
]Department of Pediatric Hematology and Oncology, Heidelberg
